Skip to main content
  • Register
  • Help
  • Contact us

Moderna to supply EU with additional 150m doses of its Covid vaccine

Wed 17 February 2021 12:58 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - The European Commission has purchased an additional 150m doses of Moderna's Covid-19 vaccine, due to be delivered in the third and fourth quarter of the year.

Moderna's chief executive officer, Stephane Bancel, said this most recent purchase brings the European Commission's total order for the company's vaccine to 310m for delivery this year.

"The European Commission is in discussions with us on how to prepare for 2022, including addressing potential variants, and the Commission has an option for an additional 150 million doses for delivery in 2022," Bancel said. "Moderna is committed to working relentlessly to bring to market vaccine boosts with the relevant variants to address this global pandemic."

Also on Wednesday, Pfizer and BioNTech agreed to supply the EU with an additional 200 million doses of their Covid-19 vaccine. The European Commission also has an option to request the supply of an extra 100m doses.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.

    More company news from ShareCast